Phase 1 and 2 Studies Demonstrate the Safety and Efficacy of Intraprostatic Injection of PRX302 for the Targeted Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
- 31 May 2011
- journal article
- research article
- Published by Elsevier BV in European Urology
- Vol. 59 (5), 747-754
- https://doi.org/10.1016/j.eururo.2010.11.024
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- A Prostate-Specific Antigen-Activated Channel-Forming Toxin as Therapy for Prostatic DiseaseJNCI Journal of the National Cancer Institute, 2007
- Five-Year Follow-up of Feedback Microwave Thermotherapy Versus TURP for Clinical BPH: A Prospective Randomized Multicenter StudyUrology, 2007
- Does PSA play a role as a promoting agent during the initiation and/or progression of prostate cancer?The Prostate, 2006
- Medical and minimally invasive therapies for the treatment of benign prostatic hyperplasiaProstate Cancer and Prostatic Diseases, 2006
- Transurethral microwave thermotherapy for the treatment of BPH: still a challenger?World Journal of Urology, 2006
- Enlarged prostate: A landmark national survey of its prevalence and impact on US men and their partnersProstate Cancer and Prostatic Diseases, 2005
- Combination Therapy for the Pharmacological Management of Benign Prostatic HyperplasiaDrugs & Aging, 2005
- Efficacy and Safety of Long-Term Treatment with the Dual 5α-Reductase Inhibitor Dutasteride in Men with Symptomatic Benign Prostatic HyperplasiaEuropean Urology, 2004
- Prostate operations: long-term effects on sexual and urinary function and quality of life. Comparison with an age-matched control populationUrological Research, 2004
- Crossing three membranes Channel formation by aerolysinFEBS Letters, 1992